Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 548ar (MIR548AR) is a member of the primate-specific miR-548 gene family, encoding a short non-coding RNA molecule that regulates gene expression at the post-transcriptional level[5][8]. Like other microRNAs, miR-548ar binds to specific messenger RNAs (mRNAs), most commonly within the 3' untranslated region, leading to reduced protein translation or mRNA destabilization[4]. The miR-548 family participates in various biological processes and signaling pathways, such as MAPK and Wnt pathways[1][8]. miR-548ar-5p has been identified as a diagnostic or prognostic biomarker in pathology, particularly as a downregulated marker in certain thyroid tumors where its measurement may help distinguish benign from malignant follicular-patterned lesions[1]. Hundreds of potential mRNA targets are predicted for miR-548ar, but the precise disease associations and mechanisms require further experimental confirmation[1][8]. There are no approved drugs known to specifically target this microRNA. - miR-548ar is not a receptor, enzyme, or classical therapeutic target; its main known role is regulatory, as with other microRNAs[4][5][8]. - It is studied primarily as a biomarker rather than a direct target for drug therapy[1]. - There is no evidence of significant safety concerns related to direct targeting or modulation of miR-548ar; its roles in normal physiology and diseases are still being elucidated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 548ar (MIR548AR).